ARNA Financial Facts

Cost of manufacturing services: 1.65M
Other: 32K
See Full Income Statement

Derivative liabilities, less current portion: 10.19M
Acquired technology and other intangibles, net: 10.07M
See Full Balance Sheet

Earnings History for Arena Pharmaceuticals, Inc. (ARNA)

  |   Expand Research on ARNA
Next EPS Date 8/8/13 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -69.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +4.6%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/2/13 Q113 $0.09$0.11 -$0.02N/A$50.36M N/A / N/A N/A -4.6% Details
3/4/13 Q412 -$0.10-$0.03 -$0.07$1.94M$21.94M N/A / N/A N/A -4% Details
11/6/12 Q312 -$0.07-$0.09 +$0.02$1.49M$3.51M N/A / N/A N/A +5.8% Details
8/9/12 Q212 -$0.12-$0.08 -$0.04$22M$7.38M N/A / N/A N/A +8.1% Details
3/14/12 Q411 -$0.16-$0.15 -$0.01$2.08M$3.49M N/A / N/A N/A +347.5% Details
11/9/11 Q311 -$0.16-$0.14 -$0.02$3.46M$3.37M N/A / N/A N/A +489% Details
8/9/11 Q211 -$0.16-$0.16 $0.00$3.26M$3.35M N/A / N/A N/A +472.1% Details
5/10/11 Q111 -$0.35-$0.21 -$0.14$3.92M$3.29M N/A / N/A N/A +493.3% Details
Like ARNA Earnings? Also take a look at VVUS, OREX, FB, GSK

ARNA Earnings News